| Multi-target approaches to CNS repair: olfactory mucosa-derived cells and heparan sulfates SL Lindsay, GA McCanney, AG Willison, SC Barnett Nature Reviews Neurology 16 (4), 229-240, 2020 | 59 | 2020 |
| Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunity T Ruck, S Barman, A Schulte-Mecklenbeck, S Pfeuffer, F Steffen, C Nelke, ... Brain 145 (5), 1711-1725, 2022 | 37 | 2022 |
| Multifaceted transforming growth factor-beta (TGFβ) signalling in glioblastoma JL Birch, BJ Coull, LC Spender, C Watt, A Willison, N Syed, AJ Chalmers, ... Cellular Signalling 72, 109638, 2020 | 37 | 2020 |
| A scoping review of trials for cell-based therapies in human spinal cord injury AG Willison, S Smith, BM Davies, MRN Kotter, SC Barnett Spinal Cord 58 (8), 844-856, 2020 | 33 | 2020 |
| The current standing of autologous haematopoietic stem cell transplantation for the treatment of multiple sclerosis AG Willison, T Ruck, G Lenz, HP Hartung, SG Meuth Journal of neurology 269 (7), 3937-3958, 2022 | 24 | 2022 |
| An optimized and validated protocol for inducing chronic experimental autoimmune encephalomyelitis in C57BL/6J mice N Huntemann, A Vogelsang, L Groeneweg, A Willison, AM Herrmann, ... Journal of Neuroscience Methods 367, 109443, 2022 | 22 | 2022 |
| Detecting ongoing disease activity in mildly affected multiple sclerosis patients under first-line therapies L Masanneck, L Rolfes, L Regner-Nelke, A Willison, S Räuber, F Steffen, ... Multiple Sclerosis and Related Disorders 63, 103927, 2022 | 18 | 2022 |
| All patients with diabetes should have annual UACR tests. Why is that so hard? A Willison, V Tully, P Davey BMJ Open Quality 5 (1), u209185. w3747, 2016 | 16 | 2016 |
| Platelet inhibition by low-dose acetylsalicylic acid reduces neuroinflammation in an animal model of multiple sclerosis A Vogelsang, S Eichler, N Huntemann, L Masanneck, H Böhnlein, ... International journal of molecular sciences 22 (18), 9915, 2021 | 13 | 2021 |
| Real-world evidence on siponimod treatment in patients with secondary progressive multiple sclerosis L Regner-Nelke, M Pawlitzki, A Willison, L Rolfes, SH Oezalp, C Nelke, ... Neurological Research and Practice 4 (1), 55, 2022 | 12 | 2022 |
| Gathering global perspectives to establish the research priorities and minimum data sets for degenerative cervical myelopathy: sampling strategy of the first round consensus … OD Mowforth, DZ Khan, MY Wong, GAE Pickering, L Dean, J Magee, ... Global spine journal 12 (1_suppl), 8S-18S, 2022 | 12 | 2022 |
| SARS-CoV-2 Vaccination and Neuroimmunological Disease: A Review AG Willison, M Pawlitzki, MP Lunn, HJ Willison, HP Hartung, SG Meuth JAMA neurology, 2024 | 11 | 2024 |
| Myositis in Germany: epidemiological insights over 15 years from 2005 to 2019 M Pawlitzki, L Acar, L Masanneck, A Willison, L Regner-Nelke, C Nelke, ... Neurological Research and Practice 4 (1), 62, 2022 | 8 | 2022 |
| Vaccine-based clinical protection against SARS-CoV-2 infection and the humoral immune response: A 1-year follow-up study of patients with multiple sclerosis receiving ocrelizumab S Räuber, A Willison, M Korsen, T Kölsche, KS Golombeck, B Plaack, ... Frontiers in Immunology 13, 1037214, 2022 | 8 | 2022 |
| Current provision of myelopathy education in medical schools in the UK: protocol for a national medical student survey O Mowforth, B Davies, M Stewart, S Smith, A Willison, S Ahmed, ... BMJ open 10 (8), e035563, 2020 | 8 | 2020 |
| Effect of previous disease-modifying therapy on treatment effectiveness for patients treated with ocrelizumab S Pfeuffer, L Rolfes, J Ingwersen, R Pul, K Kleinschnitz, M Korsen, ... Neurology: Neuroimmunology & Neuroinflammation 10 (3), e200104, 2023 | 7 | 2023 |
| Review and meta-analysis of neuropsychological findings in autoimmune limbic encephalitis with autoantibodies against LGI1, CASPR2, and GAD65 and their response to immunotherapy C Mueller, S Elben, GS Day, P Alves, J Hebert, DF Tang-Wai, O Holtmann, ... Clinical Neurology and Neurosurgery 224, 107559, 2023 | 7 | 2023 |
| Degenerative cervical myelopathy education in UK medical schools: a national cross-sectional survey of medical students JFM Brannigan, BM Davies, M Stewart, S Smith, A Willison, S Ahmed, ... British Journal of Neurosurgery 36 (6), 728-736, 2022 | 4 | 2022 |
| Eculizumab treatment alters the proteometabolome beyond the inhibition of complement C Nelke, CB Schroeter, F Stascheit, N Huntemann, M Pawlitzki, A Willison, ... JCI insight 8 (13), 2023 | 3 | 2023 |
| Ofatumumab-induced severe reactivation of psoriasis in a patient with multiple sclerosis T Kölsche, AG Willison, SG Meuth, M Pawlitzki, M Horbrügger, ... Multiple Sclerosis Journal, 13524585241260564, 2024 | 2 | 2024 |
